Key result
Pharmacist-led education increases statin treatment belief scores ~2.5 points vs. standard care.
Why the study?
Many patients with hyperlipidemia do not adhere to proper medication usage instructions, motivating an evaluation of how pharmacist-led education affects treatment beliefs and compliance in statin-treated patients.
Does face-to-face education by a pharmacist improve patient beliefs about the proper use of statin medications at 6 weeks in hospitalized patients with cardiovascular disease and hyperlipidemia?
RCT (n=50)
Assessor and data analyst blinded
Blocked Randomization (1:1 using envelopes with two A and two B codes)
No
Does face-to-face education by a pharmacist improve patient beliefs about the proper use of statin medications at 6 weeks in hospitalized patients with cardiovascular disease and hyperlipidemia?
Face-to-face pharmacist counseling significantly improves patients' beliefs regarding the necessity and proper use of statins, which may support better medication adherence in hyperlipidemia management.
Answers are grounded in this paper and cite their sources.
Supports pharmacist education in statin-treated CVD patients; extends RCT evidence for belief-targeted adherence interventions.
Introduction: Hyperlipidemia is one of the most common chronic diseases found in millions of people. Studies have shown that the patient’s adherences to medication instructions provided by the pharmacist or doctor are important, yet unfortunately many patients do not adhere to proper usage of these drugs. The aim of this study was the evaluation of the effect of education by pharmacists for hyperlipidemic patients treated with statins on patient beliefs about the proper use of medications and compliance. Methods: In this interventional clinical trial study, the studied population was all hospitalized patients with heart disease treated with statins at Hamadan Farshchian hospital from January 2016 to June 2016. The sample size in this study was 50. Information was obtained in relation to each patient, using 2 questionnaires including demographic characteristics and beliefs questionnaire. Data were analyzed using the SPSS.19 software and t test, Mann-Whitney, and X2 tests. Significance level was considered less than 0.05 Results: Statistical test results showed that before the intervention, treatment belief was not significantly different between the 2 groups (P = 0.54), yet after the intervention the treatment belief increased in the intervention group (P = 0.007) and concern about using the drug declined. Conclusions: These findings suggest that education by pharmacists in patients with hyperlipidemia could have a positive and effective role on their belief about the proper use of drugs. In other words, it could have a role in the control of chronic diseases and could help promote public health.
No takes yet. Share an insight, caveat, or question.
Mehrpooya et al. (2017) conducted an RCT in Hyperlipidemia and cardiovascular disease treated with statins (n=50). Pharmacist-led face-to-face medication and lifestyle education vs. Standard care without pharmacist education (both groups on oral statins 10, 20, or 40 mg) was evaluated on Mean treatment belief score (necessity minus concern differential on Beliefs about Medicines Questionnaire [BMQ]) at 6 weeks (p=0.007). Pharmacist-led education significantly increased mean treatment belief scores at 6 weeks compared to standard care (5.04 vs 2.52, P = 0.007) in statin-treated patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: